Member Info for Runner-Runner

Who bought £1.6m at 5.9p Fishy?

Exactly Guzzler,

Not to mention the rushed placing and attached further dilutionary warrants came just days after telling us we didn't need more cash and that the almost expired (at the time) 0.5p warrants, were not getting extended.

City. You seem to get very frustrated with the opinions on this board. As a 5% holder you must have much more of a personal relationship with the MOS board than the rest of us. You seem to have little trouble trusting them implicitly.

However, for the rest of us. We can only form our opinions on what we see happening in front of us. On the RNS's that get released, on the presentations they do and on the questions they answer.

It does now seem that the flurry of RNS activity in the build up to the 0.5p options expiry was indeed a concerted effort to get them exercised.

I have a very large bet on MOS for what they are trying to acheive in what I believe will be a very lucrative space. They have (if they can be believed) just the right tools and vision to demand a significant buy out price in the future.

However, the last 8 weeks or so has certainly given me reason to look for red flags here.

At this moment I see some orange ones, but it wouldn't take much more shady behaviour from the bod to turn them red.

There may be reasons for the delay elrico. But there are no excuses.

For all that you said, the most likely reason for the delay is utter incompetence.

Do us all a favour Watching.

Buy the lady some coffee will you.

There may or may not have been a delay to Croft. However, we were told there would be a 9m onth lock in. It has already overrun by 12 days. We have had no explanation from anyone as to why or indeed when we can expect our Poolbeg shares to be tradeable.

As usual, the finger of blame needs to point to CF. It has been a total feck up from the start. I actually cannot believe more noise wasn't made about CF actually inviting his rich friends to come along and buy our shares off us at a 40% discount. Shares, many would have paid well over 30p for Open Orphan stock to acquire in the first place.

Does anyone actually believe a word he says anymore? Genuine question.

I disagree Chief,

It was never funny.

"This is because of the weak shareholder base. On a fully diluted basis, the directors and 3 institutional shareholders only have 15% of the equity with the balance being held by multiple smaller shareholders. I would suggest that if someone were to offer a premium of say 40% over SP, then as is usual with such matters, many shareholders might be tempted by ‘the bird in hand’ rather than waiting for the results of the first in human trial"

Weak shareholder base? Does being a small shareholder also make them stupid then sailorgirl?

You are truly blessed to be rich AND highly intelligent.

As has been said many times here. Either the pre|CISION platform works or it doesn't. The difference in Avacta's market cap between those 2 outcomes is in the $billions. I am certain even most "small" shareholders can see that.

"Mmmmm...I posted quite a snotty question about the deal with Moderna being dropped/not mentioned any more in the Investor Meet Q&A section ...wonder if that had anything to do with the changes... !!!"

I did too Bella. I suspect many others also. Shows they are at least reading the questions I think.

He said he wanted to be able to take it forward (AVA6000) themselves as this would create more value for the company and shareholders. However, to do that, they are still going to require more funds. These he would want to raise in non-dilutive fashion if possible through partnerships and or licencing to develop some of the other chemo's on their list. But he wants prodox to be kept in house.

This is why the data around mid year is so important. It needs to be good enough for such deals to take place to secure the finances, before the cash runs out next year.

LFT not dropped (officially yet but why not?)

It really isn't Doggy.

Revenues for the Diagnostics Division were £0.78 million (2020: £0.52 million), with the increase coming from a licensing agreement with Astrea Bioseparations together with a smaller number of custom Affimer® reagent projects and a small amount of revenue from the sale of the AffiDx® SARS-CoV-2 antigen lateral flow tests.

Finally now there for all to see. They barely sold any Covid tests. Probably less than £50k worth from the worlds best test in a global pandemic.

Why would they waste more cash on it?

"RR, if they do mark us down, I’m on the opinion that it won’t be due to the short term future prospects of the company (AVA6K), ie reasons to remain invested, but instead an opportunity to ‘get some on the cheap"

Yes Tom. Agreed. That's why I think tomorrow could well see sub 60p, if Al gives them half a chance.

I am just countering your claim that sub 60p is looking less likely as each day passes. We need to get through tomorrow first before we can be confident of that.

humble pie !

I also feel he needs to give us something new in the presentation tomorrow. His last few have been rinse and repeat exercises that have gone down like a lead balloon.

I am looking for much more honesty/transparency tomorrow on all aspects of the business - Alastair has a lot of huble pie to eat to get the market back on side.

If we can come through tomorrow largely unscathed, then I agree, however, the Market Makers do love to knock us down on poor numbers and Al's disapoining presentations. I think it is quite likely we will see sub 60p tomorrow Tom, if numbers are poor (which I am expecting by the way).

Hopefully Al can give us enough substance to stop an early 20% markdown tomorrow. If he does, then I can start to feel a little more confident that we have turned the corner and that maybe we can have more SP stability going forward.

MyLuck.

Here is some great advice for you for free bud.

Stop throwing your money away on investing in shares. Instead, spend your money wisely by investing in a few more brain cells. They are clearly very much needed.

No need to thank me. It was my pleasure.

Hurst

Considering every single one of your short term SP predictions for ages have been horrifically wrong. And considering we are likely to be posting heavy losses thanks to the LFT debacle. And considering that all of Alastair's recent waffly presentations have led to large declines in the SP. I would wager that waiting until the end of next week to buy more might be more rewarding.

The pump this week doesn't feel rock solid to me, at least in the short term.

Very, very happy to be proved wrong though. Although that doesn't happen very often as far as Avacta is concerned.

Let's see what next week brings.

Get the frustration here and the trust issues. Feel they have to come clean about what has happened since the Webinar to try to rebuild that trust. Also a better explanation behind the rationale for the Gfinity investment and Krunch buyout that has caused such dilution to existing holders "out of the loop" and not in a position to invest more right now.

Got my pinch of salt at the ready.

Interested to know Hurst.

What planet are you from?

"At the time ME addressed people at the AJ Bell presentation there was no need to raise and that will have been the case but I suspect the Gfin situation urgently created a new plan"

Hull.

They didn't see the Gfinity opportunity, do their full due dilligence, organise a placing and get it fully subscribed and completed all in 10 days did they?

Still invested here with a large holding. Had little choice to trim this morning though simply based on an increased risk posed by ME's misleading statements.

Will certainly be watching and listening a lot more carefully and sniffing for BS much more from now on though.

The chat and misery isn't around the placing as such. We all know that companies need to raise money to grow and in this space, if you don't, you are in danger of getting left behind.

The issue is that the CEO looked investors in the eye less than 2 weeks ago and gave a deliberate and misleading answer when questioned on warrants and fundraising., essentially clearly stating that the very thing that has been RNS'd today would not be happening.

Of course, he could hide under any number of technicalities against those accusations but, in the world of AIM, where the integrity of CEO's is always under close scrutiny (and often for good reason), he has firmly put himself back into the wolf pack today.